N. Dong

Triweekly Oxaliplatin Plus Oral Capecitabine as First-Line Chemotherapy in Elderly Patients With Advanced Gastric Cancer

Zhifang Liu, Hui-qin Li, Xiaoqing Xu, 2009, American journal of clinical oncology.

Non‐genetic risk factors and predicting efficacy for docetaxel–drug‐induced liver injury among metastatic breast cancer patients

Z. Wang, H. Lyerly, Jun Ren, 2012, Journal of gastroenterology and hepatology.

Detection methods of synchronous colorectal lesions in proximal colon for patients with obstructive colorectal cancer: a literature review

Shutian Zhang, N. Dong, Da Qin, 2022, Expert review of gastroenterology & hepatology.

The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa

H. Kim Lyerly, Jun Ren, Jing Yu, 2015, Scientific Reports.

Driver and targetable alterations in Chinese patients with small bowel carcinoma

Chenghai Zhang, Jun Li, Xiaomo Li, 2023, Journal of Cancer Research and Clinical Oncology.

Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer

Yongchun Cui, Hui-qin Li, Mingyu Wang, 2012, Cancer Chemotherapy and Pharmacology.

Gemcitabine plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.

Y. Jiao, Mingyu Wang, N. Dong, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Genetic polymorphisms in cytochrome P450 and clinical outcomes of FOLFIRI chemotherapy in patients with metastatic colorectal cancer

F. Meng, Yongchun Cui, Mingyu Wang, 2015, Tumor Biology.

Clinical characteristics and treatments of cap polyposis: a single center case series

N. Dong, R. Cheng, Chuntao Liu, 2023, Gastroenterology report.